Provided By Globe Newswire
Last update: Jan 5, 2023
– Determination of Recommended Phase 2 Dose and Start of Phase 2 in 1Q 2023 for Oral Fadraciclib –
– 2/3 Partial Responses in Lymphoma and 11/15 Stable Disease in Advanced Solid Tumors –
Read more at globenewswire.comNASDAQ:CYCC (5/12/2025, 3:54:59 PM)
3.54
+3.29 (+1316%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (5/8/2025, 8:00:01 PM)
4.05
+0.31 (+8.29%)
Find more stocks in the Stock Screener
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Let's have a look at the stocks with an unusual volume in today's session.
Let's have a look at the gap up and gap down stocks in today's session.
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.